NCT04895943

Bariatric Endoscopy and NAFLD

Influence of Bariatric Endoscopy on Clinical Course of NAFLD

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 60 (actual)
• Sponsor: University Hospital Ostrava · Academic / Other
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

Find out how bariatric endoscopy will influence the clinical course of non-alcoholic fatty liver disease.

Detailed description

The study will test and investigate the impact of bariatric endoscopy (various types of intragastric balloons, endoscopic sleeve gastroplasty, aspiration therapy) on components of the metabolic syndrome in obese patients, especially on influencing non-alcoholic steatosis and steatohepatitis and signs of liver fibrotization and weight reduction. The method consists of performing a mini-invasive endoscopic procedure and, as a result, reduced food intake.

Conditions

• Obesity
• NAFLD
• Liver Steatosis
• Liver Fibrosis

Interventions

Type	Name	Description
PROCEDURE	bariatric endoscopy, mainly intragastric balloons, plication of the stomach too	bariatric endoscopy, mainly intragastric balloons, plication of the stomach too
PROCEDURE	bariatric endoscopy, mainly intragastric balloons, plication of the stomach too	bariatric endoscopy, mainly intragastric balloons, plication of the stomach too

Timeline

• Start date: 2021-04-29
• Primary completion: 2023-12-31
• Completion: 2024-12-31
• First posted: 2021-05-21
• Last updated: 2024-01-18

Locations

1 site across 1 country: Czechia